Cargando…

Clinical outcomes of patients with COVID-19 and inflammatory rheumatic diseases receiving biological/targeted therapy

BACKGROUND: Anti-cytokine treatments are used in the treatment of severe COVID-19. Other studies have shown statistical significance with TNF inhibitors but not with other biological/targeted synthetic disease-modifying anti-rheumatic drugs (b/tsDMARD). OBJECTIVES: Compare the rate of severe acute r...

Descripción completa

Detalles Bibliográficos
Autores principales: Pehlivan, Özlem, Aydin, Tutku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: King Faisal Specialist Hospital and Research Centre 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167456/
https://www.ncbi.nlm.nih.gov/pubmed/35658585
http://dx.doi.org/10.5144/0256-4947.2022.155